Filed before 2025Filed 3 November 2021
Antiva Biosciences, Inc. raised $15.6M
Antiva Biosciences, Inc., a biotech company based in Brisbane, CA, raised $15.6M in a new equity round, according to a filing dated 3 November 2021.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 3 November 2021
- Round
- Equity round
- Amount sold
- $15.6M
- Offering size
- $31M
- Investors so far
- 20
- Based in
- Brisbane, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 58% of the 2,220 tracked raises with an amount filed in 2021, and than 44% of the 177 in biotech.
Antiva Biosciences, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 3 Nov 2021 | New filing | $15.6M | This raise |
| 28 Aug 2017 | Amended filing | $14.7M | Another raise |
| 5 Apr 2017 | New filing | $11.1M | Another raise |
| 11 Jun 2015 | New filing | $8.91M | Another raise |
More with HealthQuest on the board
- 83Bar, Inc.$7.5M
- Solaborate Inc.$47M
- Venus Concept Inc.$1.1M
- Home Hospital Newco, Inc.$30M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.